文献速递慢阻肺哮喘呼吸道感染

肺功能正常者慢性呼吸道症状的预后意义

Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry.
PubMed 文献 · Eur Respir J · 2019-09-19

结果显示,慢性呼吸道症状与气道疾病急性加重住院、肺炎住院、呼吸系统死亡及全因死亡风险升高相关,且症状数量与风险呈剂量反应关系。

要点

  • 肺功能正常但伴慢性呼吸道症状者气道疾病急性加重住院风险升高(HR 1.62)。
  • 此类个体肺炎住院、呼吸系统死亡及全因死亡风险亦显著升高。
  • 症状数量与不良结局风险呈正相关,提示症状负荷的预后价值。

核心结论

  • 在肺功能正常且无已知气道疾病个体中,慢性呼吸道症状与呼吸系统住院和死亡风险升高独立相关。

研究设计与样本

  • 肺功能正常定义为支气管舒张前FEV1/FVC≥0.70,慢性呼吸道症状包括呼吸困难、慢性黏液高分泌、喘息和咳嗽。
  • 随访2003年至2018年,评估气道疾病急性加重住院、肺炎住院、呼吸系统死亡和全因死亡风险。

主要发现

  • 随访期间共观察1037例气道疾病急性加重住院、5743例肺炎住院和8750例死亡,其中463例为呼吸系统死亡。
  • 与肺功能正常无慢性呼吸道症状者相比,有症状者多变量校正HR:急性加重住院1.62(95%CI 1.20-2.18),肺炎住院1.26(95%CI 1.17-1.37)。
  • 有症状者呼吸系统死亡HR 1.59(95%CI 1.22-2.06),全因死亡HR 1.19(95%CI 1.13-1.25)。
  • 症状数量与结局风险呈正剂量反应关系,随访2年后、仅从不吸烟者及单症状分析结果相似。

临床怎么用

  • 对肺功能正常但主诉慢性呼吸道症状者,不应仅凭肺功能正常排除未来呼吸系统不良结局风险。
  • 需关注症状数量负荷,症状多者可能需更密切随访和干预。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Normal spirometry is often used to preclude airway disease in individuals with unspecific respiratory symptoms. We tested the hypothesis that chronic respiratory symptoms are associated with respiratory hospitalisations and death in individuals with normal spirometry without known airway disease.We included 108 246 randomly chosen individuals aged 20-100 years from a Danish population-based cohort study. Normal spirometry was defined as a pre-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio ≥0.70. Chronic respiratory symptoms included dyspnoea, chronic mucus hypersecretion, wheezing and cough. Individuals with known airway disease, i.e. chronic obstructive pulmonary disease and/or asthma, were excluded (n=10 291). We assessed risk of hospitalisations due to exacerbations of airway disease and pneumonia, and respiratory and all-cause mortality, from 2003 through 2018.52 999 individuals had normal spirometry without chronic respiratory symptoms and 30 890 individuals had normal spirometry with chronic respiratory symptoms. During follow-up, we observed 1037 hospitalisations with exacerbation of airway disease, 5743 hospitalisations with pneumonia and 8750 deaths, of which 463 were due to respiratory disease. Compared with individuals with normal spirometry without chronic respiratory symptoms, multivariable adjusted hazard ratios for individuals with normal spirometry with chronic respiratory symptoms were 1.62 (95% CI 1.20-2.18) for exacerbation hospitalisations, 1.26 (95% CI 1.17-1.37) for pneumonia hospitalisations, 1.59 (95% CI 1.22-2.06) for respiratory mortality and 1.19 (95% CI 1.13-1.25) for all-cause mortality. There was a positive dose-response relationship between number of symptoms and risk of outcomes. Results were similar after 2 years of follow-up, for never-smokers alone, and for each symptom separately.Chronic respiratory symptoms are associated with respiratory hospitalisations and death in individuals with normal spirometry without known airway disease.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Çolak Y, Nordestgaard BG, Vestbo J, et al. Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry. Eur Respir J. 2019. PMID: 31248954. doi:10.1183/13993003.00734-2019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。